Related Experiment Video

Updated: Aug 12, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

Considerations for pediatric trial designs and analyses

Meehyung Cho1, Zhiying Qiu1, Jenny Ye1

  • 1a Biostatistics and Programming , Sanofi US , Bridgewater , NJ , USA.

Journal of Biopharmaceutical Statistics
|September 6, 2017
PubMed

Insights

Designing pediatric clinical trials is challenging due to ethical concerns and limited patient numbers. This study proposes innovative methods using adult data to improve pediatric trial design, enhancing efficiency and reliability for rare diseases.

Area of Science:

  • Clinical Trials Methodology
  • Pediatric Research
  • Biostatistics

Background:

  • Pediatric clinical trials face unique ethical considerations and smaller patient populations, making traditional Phase 3 designs often impractical.
  • Existing trial designs struggle to adequately address the specific needs and constraints of pediatric drug development.
  • The scarcity of pediatric patients necessitates novel approaches to ensure robust and ethical trial outcomes.

Purpose of the Study:

  • To develop and evaluate advanced statistical methods for designing pediatric clinical trials.
  • To leverage existing adult study data effectively within pediatric trial frameworks.
  • To enhance the feasibility and ethical integrity of pediatric drug development studies.

Main Methods:

  • Application of James-Stein shrinkage estimation and empirical shrinkage estimation.
  • Utilization of Bayesian statistical methods for data integration.
  • Adaptation of multi-regional trial consistency concepts to pediatric trial design.

Main Results:

  • Proposed methods demonstrate improved performance in representative pediatric trial scenarios.
  • The approaches effectively incorporate adult data, addressing sample size limitations.
  • An example using Type 2 diabetes mellitus (T2DM) trials illustrates the practical application and benefits.

Conclusions:

  • Innovative statistical methods can overcome challenges in pediatric trial design.
  • Leveraging adult data through shrinkage estimation and Bayesian approaches enhances pediatric study efficiency.
  • These advanced designs offer a more realistic and ethical pathway for pediatric drug development.

Keywords:
Bayesian methodJames–Stein shrinkage estimationempirical shrinkage estimationpediatricsample sizeweighted combination

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

An Electrophysiology Protocol to Measure Reward Anticipation and Processing in Children05:04

An Electrophysiology Protocol to Measure Reward Anticipation and Processing in Children

Published on: October 4, 2018

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...